Evidence map›Paper›PMID 30842650›Full record

ReviewNature reviews. Endocrinology2019

Endocrine disruptors and the future of toxicology testing - lessons from CLARITY-BPA.

Laura N Vandenberg, Patricia A Hunt, Andrea C Gore

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Endocrine-Disrupting Chemicals: Science and Policy.Policy insights from the behavioral and brain sciences · 2023
    Article
  17. Review
  18. Article
  19. Science, Values, and the New Demarcation Problem.Journal for general philosophy of science = Zeitschrift fur allgemeine Wissenschaftstheorie · 2023
    Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura N VandenbergDepartment of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts-Amherst, Amherst, MA, USA.
Patricia A HuntCenter for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, WA, USA.
Andrea C GoreDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA. andrea.gore@austin.utexas.edu.ORCID http://orcid.org/0000-0001-5549-6793

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five years ago, an ambitious collaboration, the Consortium Linking Academic and Regulatory Insights on Toxicity of BPA (CLARITY-BPA; henceforth CLARITY), was launched by three US agencies. The goal was to provide a definitive evaluation of bisphenol A (BPA) and explain disparities between traditional regulatory studies and findings from independent investigators. BPA or vehicle-treated rats from an FDA facility were used in a guideline study and animals and/or tissues were provided to academic researchers for analysis. An interim summary released in February 2018 by the FDA concluded that currently authorized uses of BPA continue to be safe. We disagree. In this Perspectives, we summarize the goals, design and problems of CLARITY. We conclude that, despite its flaws, CLARITY provides important insight and, taken together, the data provide compelling evidence that low-dose BPA exposure induces marked adverse effects. Indeed, the greatest number of effects were observed at doses 20,000 times lower than the current 'safe' dose of BPA for humans.

Indexed as

AnimalsBenzhydryl CompoundsBisphenol A CompoundsDrug Evaluation, PreclinicalEndocrine DisruptorsHumansPhenolsToxicity TestsUnited StatesUnited States Food and Drug AdministrationBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEndocrine DisruptorsPhenols

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.